Seguir
Stanley Stylli
Stanley Stylli
The University of Melbourne; The Royal Melbourne Hospital
E-mail confirmado em mh.org.au - Página inicial
Título
Citado por
Citado por
Ano
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
JA Welsh, DCI Goberdhan, L O'Driscoll, EI Buzas, C Blenkiron, ...
Journal of extracellular vesicles 13 (2), e12404, 2024
6192024
Photodynamic therapy of high grade glioma–long term survival
SS Stylli, AH Kaye, L MacGregor, M Howes, P Rajendra
Journal of clinical neuroscience 12 (4), 389-398, 2005
2752005
Invadopodia: at the cutting edge of tumour invasion
SS Stylli, AH Kaye, P Lock
Journal of clinical neuroscience 15 (7), 725-737, 2008
2582008
Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma.
JS Hill, SB Kahl, AH Kaye, SS Stylli, MS Koo, MF Gonzales, NJ Vardaxis, ...
Proceedings of the National Academy of Sciences 89 (5), 1785-1789, 1992
1931992
Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies
FH Tan, TL Putoczki, SS Stylli, RB Luwor
OncoTargets and therapy, 635-645, 2019
1902019
Nck adaptor proteins link Tks5 to invadopodia actin regulation and ECM degradation
SS Stylli, STT I, AM Verhagen, SS Xu, I Pass, SA Courtneidge, P Lock
Journal of cell science 122 (15), 2727-2740, 2009
1752009
Optical coherence tomography predicts visual outcome for pituitary tumors
HV Danesh-Meyer, A Wong, T Papchenko, K Matheos, S Stylli, A Nichols, ...
Journal of Clinical Neuroscience 22 (7), 1098-1104, 2015
1542015
The emergent role of exosomes in glioma
J Gourlay, AP Morokoff, RB Luwor, HJ Zhu, AH Kaye, SS Stylli
Journal of Clinical Neuroscience 35, 13-23, 2017
1472017
The role of Stat3 in glioblastoma multiforme
RB Luwor, SS Stylli, AH Kaye
Journal of clinical neuroscience 20 (7), 907-911, 2013
1422013
Visual acuity and pattern of visual field loss at presentation in pituitary adenoma
S Ogra, AD Nichols, S Stylli, AH Kaye, PJ Savino, HV Danesh-Meyer
Journal of Clinical Neuroscience 21 (5), 735-740, 2014
1312014
Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin
MA Rosenthal, B Kavar, JS Hill, DJ Morgan, RL Nation, SS Stylli, ...
Journal of clinical oncology 19 (2), 519-524, 2001
1252001
Photodynamic therapy of cerebral glioma–A review Part II–Clinical studies
SS Stylli, AH Kaye
Journal of Clinical Neuroscience 13 (7), 709-717, 2006
1212006
Mouse models of glioma
SS Stylli, RB Luwor, TMB Ware, F Tan, AH Kaye
Journal of Clinical Neuroscience 22 (4), 619-626, 2015
1132015
The role of interleukin‑6‑STAT3 signalling in glioblastoma
AJ West, V Tsui, SS Stylli, H Nguyen, AP Morokoff, AH Kaye, RB Luwor
Oncology letters 16 (4), 4095-4104, 2018
1082018
Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome
SS Stylli, M Howes, L MacGregor, P Rajendra, AH Kaye
Journal of Clinical Neuroscience 11 (6), 584-596, 2004
1072004
Selective uptake of hematoporphyrin derivative into human cerebral glioma
JS Hill, AH Kaye, WH Sawyer, G Morstyn, PD Megison, SS Stylli
Neurosurgery 26 (2), 248-254, 1990
1061990
Hyaluronidase-2 overexpression accelerates intracerebral but not subcutaneous tumor formation of murine astrocytoma cells
U Novak, SS Stylli, AH Kaye, G Lepperdingerm
Cancer research 59 (24), 6246-6250, 1999
1021999
Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer.
JS Hill, SB Kahl, SS Stylli, Y Nakamura, MS Koo, AH Kaye
Proceedings of the National Academy of Sciences 92 (26), 12126-12130, 1995
971995
Photodynamic therapy of cerebral glioma–a review Part I–a biological basis
SS Stylli, AH Kaye
Journal of Clinical Neuroscience 13 (6), 615-625, 2006
912006
The role of STAT3 signaling in mediating tumor resistance to cancer therapy
F H Tan, T L Putoczki, S S Stylli, R B Luwor
Current drug targets 15 (14), 1341-1353, 2014
772014
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20